Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TED: Insulin Glargine Add-on in T2DM
NCT02027753Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2013
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2013; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02027753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027753.